Drug Eluting Stents Not Value For Money, Swiss Study

A new Swiss study has found that overall, drug-eluting stents do not offer good value for money and this would still be the case if they were considerably cheaper. They are however, cost-effective when used to treat high-risk patients with particularly narrow arteries or who have stents fitted to bypass grafts. [click link for full article]

More: continued here

Filed under: Cardiovascular on November 3rd, 2007